Crison
Crison Frequently Asked Questions (FAQ)
Where is Crison's headquarters?
Crison's headquarters is located at 2201 West Campbell Park Dr Ste 5, Chicago.
What is Crison's latest funding round?
Crison's latest funding round is Incubator/Accelerator.
Who are the investors of Crison?
Investors of Crison include Chicago Technology Park.
Who are Crison's competitors?
Competitors of Crison include Affibody, Cathay Biotech, Dyax, TaiGen Biotechnology, ugichem and 12 more.
Compare Crison to Competitors
ERA Biotech develops and implements cell-based biomanufacturing technologies.
greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins
Elevation Biotech specialises in the design and discovery of small peptide and peptidomimetic HIV attachment inhibitors. The company have developed biochemical and virological in vitro assays that screen specifically for the ability of compounds to block or interfere with viral attachment to the cell surface receptor CD4. The company's lead compound, is a short 7 amino acid peptide that binds to HIV envelope protein gp120 thereby preventing attachment of virus to the CD4 molecule.

Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.

Oligomerix is a clinical-stage biotechnology company. It focuses on developing disease-modifying therapeutics for neurodegenerative diseases characterized by the aberrant tau protein, ranging from tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. The firm serves clients in the healthcare sector. Oligomerix was founded in 2006 and is based in West Harrison, New York.
MI Research, Inc. specializes in Biotech instrumentation with excellent visualization capabilities in the area of protein crystal growth and blood viscosity measurements. MI aims to offer fluorescence base protein crystallization prescreening service and biotech instruments like blood viscometers. MI's expertise is in optics and biochemistry.